Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

HER2-positive Metastatic Breast Cancer × Drug Therapy × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 18 Neoplasm Metastasis 8 Lung Neoplasms 7 Colorectal Neoplasms 7 Breast Neoplasms 7 Esophageal Squamous Cell Carcinoma 6 Stomach Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Small Cell Lung Carcinoma 5 Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 4 Rectal Neoplasms 4 Leukemia, Myeloid, Acute 4 Head and Neck Neoplasms 4 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Fallopian Tube Neoplasms 3 Esophageal Neoplasms 3 Urinary Bladder Neoplasms 2 Sarcoma 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Oropharyngeal Neoplasms 2 Neoplasms 2 Nasopharyngeal Carcinoma 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia 2 Gastrointestinal Neoplasms 2 Colonic Neoplasms 2 Cholangiocarcinoma 2

Interventions

tucatinib 1 Fulvestrant 1 Alpelisib 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡